LEMAITRE VASCULAR, INC. Operating Cash Flow
LEMAITRE VASCULAR, INC. (LMAT) reported Operating Cash Flow of $31.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $15.96M, a 21.32% decline year-over-year.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $15.09M, a 66.98% increase year-over-year.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $23.16M, a 52.53% increase year-over-year.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $28.76M, a 101.91% increase year-over-year.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for fiscal 2025 was $81.25M, a 84.14% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for fiscal 2024 was $44.12M, a 20.06% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for fiscal 2023 was $36.75M, a 44.81% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. net cash provided by (used in) operating activities for fiscal 2022 was $25.38M, a 27.70% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $31.06M 10-Q · filed 2026-08-05 | $54.22M derived: sum of 3 quarters · filed 2026-08-05 | $82.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $15.09M 10-Q · filed 2026-05-06 | $38.25M derived: sum of 2 quarters · filed 2026-05-06 | $67.01M derived: sum of 3 quarters · filed 2026-05-06 | $87.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $23.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $51.92M derived: sum of 2 quarters · filed 2026-02-26 | $72.21M derived: sum of 3 quarters · filed 2026-08-05 | $81.25M 10-K · filed 2026-02-26 |
| 2025-09-30 | $28.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $49.05M derived: sum of 2 quarters · filed 2026-08-05 | $58.09M 10-Q · filed 2025-11-07 | $73.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $20.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $29.33M 10-Q · filed 2026-08-05 | $44.51M derived: sum of 3 quarters · filed 2026-08-05 | $58.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.04M 10-Q · filed 2026-05-06 | $24.22M derived: sum of 2 quarters · filed 2026-05-06 | $38.47M derived: sum of 3 quarters · filed 2026-05-06 | $48.09M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.43M derived: sum of 2 quarters · filed 2026-02-26 | $39.05M derived: sum of 3 quarters · filed 2026-02-26 | $44.12M 10-K · filed 2026-02-26 |
| 2024-09-30 | $14.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $23.87M derived: sum of 2 quarters · filed 2025-11-07 | $28.94M 10-Q · filed 2025-11-07 | $39.69M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $14.70M 10-Q · filed 2025-08-06 | $25.44M derived: sum of 3 quarters · filed 2026-02-26 | $37.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.07M 10-Q · filed 2025-05-08 | $15.82M derived: sum of 2 quarters · filed 2026-02-26 | $27.64M derived: sum of 3 quarters · filed 2026-02-26 | $39.54M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.57M derived: sum of 2 quarters · filed 2026-02-26 | $34.47M derived: sum of 3 quarters · filed 2026-02-26 | $36.75M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $23.73M derived: sum of 2 quarters · filed 2024-11-08 | $26.00M 10-Q · filed 2024-11-08 | $30.08M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.18M 10-Q · filed 2024-08-08 | $18.26M derived: sum of 3 quarters · filed 2025-02-28 | $25.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.28M 10-Q · filed 2024-05-10 | $6.36M derived: sum of 2 quarters · filed 2025-02-28 | $13.70M derived: sum of 3 quarters · filed 2025-02-28 | $22.95M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.42M derived: sum of 2 quarters · filed 2025-02-28 | $20.67M derived: sum of 3 quarters · filed 2025-02-28 | $25.38M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $16.59M derived: sum of 2 quarters · filed 2023-11-07 | $21.30M 10-Q · filed 2023-11-07 | $26.36M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $9.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $13.96M 10-Q · filed 2023-08-08 | $19.02M derived: sum of 3 quarters · filed 2024-02-29 | $33.09M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.71M 10-Q · filed 2023-05-09 | $9.77M derived: sum of 2 quarters · filed 2024-02-29 | $23.84M derived: sum of 3 quarters · filed 2024-02-29 | $33.74M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $19.13M derived: sum of 2 quarters · filed 2024-02-29 | $29.03M derived: sum of 3 quarters · filed 2024-02-29 | $35.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | $14.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $23.97M derived: sum of 2 quarters · filed 2022-11-08 | $30.05M 10-Q · filed 2022-11-08 | $44.20M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $9.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $15.97M 10-Q · filed 2022-08-05 | $30.12M derived: sum of 3 quarters · filed 2023-03-01 | $44.23M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $6.07M 10-Q · filed 2022-05-10 | $20.23M derived: sum of 2 quarters · filed 2023-03-01 | $34.34M derived: sum of 3 quarters · filed 2023-03-01 | $39.69M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $14.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $28.26M derived: sum of 2 quarters · filed 2023-03-01 | $33.61M derived: sum of 3 quarters · filed 2023-03-01 | $34.80M 10-K · filed 2023-03-01 |
| 2020-09-30 | $14.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $19.46M derived: sum of 2 quarters · filed 2021-11-04 | $20.65M 10-Q · filed 2021-11-04 | $26.24M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $6.54M 10-Q · filed 2021-08-05 | $12.13M derived: sum of 3 quarters · filed 2022-02-28 | $16.60M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.19M 10-Q · filed 2021-05-10 | $6.78M derived: sum of 2 quarters · filed 2022-02-28 | $11.25M derived: sum of 3 quarters · filed 2022-02-28 | $15.59M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $10.06M derived: sum of 2 quarters · filed 2022-02-28 | $14.40M derived: sum of 3 quarters · filed 2022-02-28 | $14.18M 10-K · filed 2022-02-28 |
| 2019-09-30 | $4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $8.80M derived: sum of 2 quarters · filed 2020-11-06 | $8.59M 10-Q · filed 2020-11-06 | $15.16M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.12M 10-Q · filed 2020-08-06 | $10.69M derived: sum of 3 quarters · filed 2021-03-12 | $14.99M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$219.00K 10-Q · filed 2020-05-08 | $6.35M derived: sum of 2 quarters · filed 2021-03-12 | $10.66M derived: sum of 3 quarters · filed 2021-03-12 | $15.54M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $10.88M derived: sum of 2 quarters · filed 2021-03-12 | $15.76M derived: sum of 3 quarters · filed 2021-03-12 | $19.51M 10-K · filed 2021-03-12 |
| 2018-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $9.18M derived: sum of 2 quarters · filed 2019-11-08 | $12.94M 10-Q · filed 2019-11-08 | $19.70M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $8.63M 10-Q · filed 2019-08-06 | $15.40M derived: sum of 3 quarters · filed 2020-03-12 | $23.59M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $3.75M 10-Q · filed 2019-05-06 | $10.52M derived: sum of 2 quarters · filed 2020-03-12 | $18.72M derived: sum of 3 quarters · filed 2020-03-12 | |
| 2017-12-31 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $14.97M derived: sum of 2 quarters · filed 2020-03-12 | $22.87M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $16.10M 10-Q · filed 2018-11-02 | ||
| 2017-06-30 | $7.90M 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | $16.90M 10-K · filed 2019-03-11 | |||
| 2013-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $3.75M derived: sum of 2 quarters · filed 2014-03-21 | $5.73M derived: sum of 3 quarters · filed 2014-03-21 | $5.39M 10-K · filed 2014-03-21 |
| 2013-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $4.38M derived: sum of 2 quarters · filed 2013-11-07 | $4.03M 10-Q · filed 2013-11-07 | $4.46M derived: sum of 4 quarters · filed 2014-03-21 |
| 2013-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.64M 10-Q · filed 2013-08-09 | $2.07M derived: sum of 3 quarters · filed 2014-03-21 | $3.93M derived: sum of 4 quarters · filed 2014-03-21 |
| 2013-03-31 | -$346.00K 10-Q · filed 2013-05-08 | $81.00K derived: sum of 2 quarters · filed 2014-03-21 | $1.95M derived: sum of 3 quarters · filed 2014-03-21 | $3.99M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $2.29M derived: sum of 2 quarters · filed 2014-03-21 | $4.34M derived: sum of 3 quarters · filed 2014-03-21 | $4.72M 10-K · filed 2014-03-21 |
| 2012-09-30 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $3.91M derived: sum of 2 quarters · filed 2013-11-07 | $4.29M 10-Q · filed 2013-11-07 | $3.99M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.43M 10-Q · filed 2013-08-09 | $2.13M derived: sum of 3 quarters · filed 2014-03-21 | $4.50M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $386.00K 10-Q · filed 2013-05-08 | $83.00K derived: sum of 2 quarters · filed 2014-03-21 | $2.46M derived: sum of 3 quarters · filed 2014-03-21 | $5.97M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | -$303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $2.07M derived: sum of 2 quarters · filed 2014-03-21 | $5.58M derived: sum of 3 quarters · filed 2014-03-21 | $3.17M 10-K · filed 2014-03-21 |
| 2011-09-30 | $2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.89M derived: sum of 2 quarters · filed 2012-11-09 | $3.47M 10-Q · filed 2012-11-09 | $4.44M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $1.10M 10-Q · filed 2012-08-10 | $2.07M derived: sum of 3 quarters · filed 2013-03-27 | $4.69M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | -$2.41M 10-Q · filed 2012-05-03 | -$1.45M derived: sum of 2 quarters · filed 2013-03-27 | $1.18M derived: sum of 3 quarters · filed 2013-03-27 | |
| 2010-12-31 | $969.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $3.59M derived: sum of 2 quarters · filed 2013-03-27 | $7.05M 10-K · filed 2013-03-27 | |
| 2010-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $6.08M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $3.46M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $5.44M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |